1,596 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 679 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5371,596 (+59)

1.05% more ownership

Funds ownership: 78.07%79.12% (+1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,596
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.63B
2 +$2.24B
3 +$584M
4
Barclays
Barclays
United Kingdom
+$245M
5
Goldman Sachs
Goldman Sachs
New York
+$161M

Top Sellers

1 -$1.34B
2 -$387M
3 -$149M
4
Primecap Management
Primecap Management
California
-$147M
5
O
OrbiMed
New York
-$147M
Name Holding Trade Value Shares
Change
Change in
Stake
1151
$616K
1152
$613K
1153
$612K
1154
$611K
1155
$607K
1156
$604K
1157
$601K
1158
$599K
1159
$596K
1160
$591K
1161
$590K
1162
$590K
1163
$589K
1164
$584K
1165
$583K
1166
$581K
1167
$580K
1168
$576K
1169
$576K
1170
$574K
1171
$574K
1172
$572K
1173
$569K
1174
$566K
1175
$565K